Cor Vasa 2009, 51(7-8):527-531 | DOI: 10.33678/cor.2009.132

Z kongresů, konferencí, symposií

Published: July 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Z kongresů, konferencí, symposií. Cor Vasa. 2009;51(7-8):527-531. doi: 10.33678/cor.2009.132.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alehagen U, Dahlström U, Lindahl TL. Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care. Eur J Heart Failure 2009;11:354-60; doi:10.1093/eurjhf/hfp024 Go to original source... Go to PubMed...
    2. Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure. J Am Coll Cardiol 2008;52:1458-65. Go to original source... Go to PubMed...
    3. Epelman S, Tang WH, Chen SY, et al. Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol 2008;52:750-4. Go to original source... Go to PubMed...
    4. Braumwald E. Biomarkers in heart failure. New Engl J Med 2008;358: 2148-59. Go to original source... Go to PubMed...
    5. Hare JM, Mangal B, Brown J, et al, for OPT-CHF Investigators. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 2008;51:2301-9. Go to original source... Go to PubMed...
    6. The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction - Baseline Characteristics of the Study Population. Cardiology 2008;110: 271-282; (DOI: 10.1159/000112412) Go to original source... Go to PubMed...
    7. GISSI-HF investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1231-9. Go to original source... Go to PubMed...
    8. Robert C. Bourge for COMPASS-HF Study Group. Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure: The COMPASS-HF Study. J Am Coll Cardiol 2009;51: 1073-9.
    9. Cleland JGF, Daubert J-C, Erdmann E, et al. The Cardiac Resynchronization - Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-49. Go to original source... Go to PubMed...
    10. The CRT Survey Scientific Committee European cardiac resynchronization therapy survey: rationale and design. Eur J Heart Fail 2009;11:326-330; doi:10.1093/eurjhf/hfp030

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes